Approval · Notice of Compliance 20876 · 2018
JULUCA: Notice of Compliance 20876
Issued May 18, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20876
- Date
- May 18, 2018
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JULUCA | 02475774 | Marketed |
Medicinal ingredients
- RILPIVIRINE HYDROCHLORIDE 25 MG per TAB
- DOLUTEGRAVIR SODIUM 50 MG per TAB